GlassScriptPhysician profile
Cathy M Wright
NPI 1992247332
$1,423.39
in general payments reported to CMS, 2019-2025
13 companies · $773 in 2025
The $773 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $189 · 2024: $462 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $427.43 | 2024-2025 | |
| Abbvie INC. | $263.94 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $125.00 | 2025 | |
| Globus Medical, INC. | $114.70 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $93.07 | 2025 | Austedo Xr |
| Merz Pharmaceuticals, LLC | $87.71 | 2025 | Xeomin |
| Bioventus LLC | $83.05 | 2025 | Durolane, Xcell |
| Alkermes, INC. | $68.44 | 2023 | Lybalvi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.00 | 2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $39.43 | 2025 | |
| Boston Scientific Corporation | $29.97 | 2025 | General - Pain Management |
| Collegium Pharmaceutical, INC. | $24.99 | 2025 | Xtampza |
| Medtronic, INC. | $17.66 | 2025 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.